Literature DB >> 22205826

Photochemical Preparation of a Novel Low Molecular Weight Heparin.

Kyohei Higashi1, Saori Hosoyama, Asami Ohno, Sayaka Masuko, Bo Yang, Eric Sterner, Zhenyu Wang, Robert J Linhardt, Toshihiko Toida.   

Abstract

Commercial low molecular weight heparins (LMWHs) are prepared by several methods including peroxidative cleavage, nitrous acid cleavage, chemical ß-elimination, and enzymatic β-elimination. The disadvantages of these methods are that strong reaction conditions or harsh chemicals are used and these can result in decomposition or modification of saccharide units within the polysaccharide backbone. These side-reactions reduce product quality and yield. Here we show the partial photolysis of unfractionated heparin can be performed in distillated water using titanium dioxide (TiO(2)). TiO(2) is a catalyst that can be easily removed by centrifugation or filtration after the photochemical reaction takes place, resulting in highly pure products. The anticoagulant activity of photodegraded LMWH (pLMWH) is comparable to the most common commercially available LMWHs (i.e., Enoxaparin and Dalteparin). (1)H NMR spectra obtained show that pLMWH maintains the same core structure as unfractionated heparin. This photochemical reaction was investigated using liquid chromatography/mass spectrometry (LC/MS) and unlike other processes commonly used to prepare LMWHs, photochemically preparation affords polysaccharide chains of reduced length having both odd and even of saccharide residues.

Entities:  

Year:  2012        PMID: 22205826      PMCID: PMC3245882          DOI: 10.1016/j.carbpol.2011.09.087

Source DB:  PubMed          Journal:  Carbohydr Polym        ISSN: 0144-8617            Impact factor:   9.381


  27 in total

1.  Anticoagulant properties of heparin fractionated by affinity chromatography on matrix-bound antithrombin iii and by gel filtration.

Authors:  L O Andersson; T W Barrowcliffe; E Holmer; E A Johnson; G E Sims
Journal:  Thromb Res       Date:  1976-12       Impact factor: 3.944

Review 2.  Production and chemical processing of low molecular weight heparins.

Authors:  R J Linhardt; N S Gunay
Journal:  Semin Thromb Hemost       Date:  1999       Impact factor: 4.180

3.  (1)H nuclear magnetic resonance spectroscopic analysis for determination of glucuronic and iduronic acids in dermatan sulfate, heparin, and heparan sulfate.

Authors:  M Sudo; K Sato; A Chaidedgumjorn; H Toyoda; T Toida; T Imanari
Journal:  Anal Biochem       Date:  2001-10-01       Impact factor: 3.365

4.  Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Authors:  Jack Hirsh; Robert Raschke
Journal:  Chest       Date:  2004-09       Impact factor: 9.410

5.  Purification and characterization of heparin lyases from Flavobacterium heparinum.

Authors:  D L Lohse; R J Linhardt
Journal:  J Biol Chem       Date:  1992-12-05       Impact factor: 5.157

6.  Differential anticoagulant activity of heparin fragments prepared using microbial heparinase.

Authors:  R J Linhardt; A Grant; C L Cooney; R Langer
Journal:  J Biol Chem       Date:  1982-07-10       Impact factor: 5.157

Review 7.  Pharmacodynamics, clinical indications, and adverse effects of heparin.

Authors:  M D Freedman
Journal:  J Clin Pharmacol       Date:  1992-07       Impact factor: 3.126

8.  Gradient polyacrylamide gel electrophoresis for determination of molecular weights of heparin preparations and low-molecular-weight heparin derivatives.

Authors:  R E Edens; A al-Hakim; J M Weiler; D G Rethwisch; J Fareed; R J Linhardt
Journal:  J Pharm Sci       Date:  1992-08       Impact factor: 3.534

9.  Liquid chromatography/mass spectrometry sequencing approach for highly sulfated heparin-derived oligosaccharides.

Authors:  Charuwan Thanawiroon; Kevin G Rice; Toshihiko Toida; Robert J Linhardt
Journal:  J Biol Chem       Date:  2003-11-10       Impact factor: 5.157

10.  Pharmacology of low molecular weight heparins.

Authors:  J Harenberg
Journal:  Semin Thromb Hemost       Date:  1990-10       Impact factor: 4.180

View more
  7 in total

1.  Structure and activity of a new low-molecular-weight heparin produced by enzymatic ultrafiltration.

Authors:  Li Fu; Fuming Zhang; Guoyun Li; Akihiro Onishi; Ujjwal Bhaskar; Peilong Sun; Robert J Linhardt
Journal:  J Pharm Sci       Date:  2014-03-14       Impact factor: 3.534

Review 2.  Advances in the preparation and synthesis of heparin and related products.

Authors:  Sultan N Baytas; Robert J Linhardt
Journal:  Drug Discov Today       Date:  2020-09-16       Impact factor: 7.851

Review 3.  Heparin and related polysaccharides: synthesis using recombinant enzymes and metabolic engineering.

Authors:  Matthew Suflita; Li Fu; Wenqin He; Mattheos Koffas; Robert J Linhardt
Journal:  Appl Microbiol Biotechnol       Date:  2015-07-29       Impact factor: 4.813

Review 4.  Bioengineered heparins and heparan sulfates.

Authors:  Li Fu; Matthew Suflita; Robert J Linhardt
Journal:  Adv Drug Deliv Rev       Date:  2015-11-10       Impact factor: 15.470

5.  Fucosylated chondroitin sulfates from the body wall of the sea cucumber Holothuria forskali: conformation, selectin binding, and biological activity.

Authors:  Charalampos G Panagos; Derek S Thomson; Claire Moss; Adam D Hughes; Maeve S Kelly; Yan Liu; Wengang Chai; Radhakrishnan Venkatasamy; Domenico Spina; Clive P Page; John Hogwood; Robert J Woods; Barbara Mulloy; Charlie D Bavington; Dušan Uhrín
Journal:  J Biol Chem       Date:  2014-08-21       Impact factor: 5.157

6.  Poly-ion complex (PIC) formation of heparin and polyamines: PIC with tetrakis (3-aminopropyl) ammonium allows sustained release of heparin.

Authors:  Daichi Ito; Dan Ge; Noriyuki Kogure; Hitomi Manaka; Yusuke Terui; Hiromitsu Takayama; Robert J Linhardt; Toshihiko Toida; Kyohei Higashi
Journal:  Heliyon       Date:  2020-10-06

7.  Ischemic stroke disrupts the endothelial glycocalyx through activation of proHPSE via acrolein exposure.

Authors:  Kenta Ko; Takehiro Suzuki; Ryota Ishikawa; Natsuko Hattori; Risako Ito; Kenta Umehara; Tomomi Furihata; Naoshi Dohmae; Robert J Linhardt; Kazuei Igarashi; Toshihiko Toida; Kyohei Higashi
Journal:  J Biol Chem       Date:  2020-10-30       Impact factor: 5.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.